Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Stone

Showing results (501-510 of 544) with videos related to

Pageof 55
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2010
Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28Jacalyn Rosenblatt, Zekui Wu, Baldev Vasir, et al.
Leukemia|January 25, 2021
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
The Medical Journal of Australia|June 1, 2022
Value of single troponin values in the emergency department for excluding acute myocardial infarction in Aboriginal and Torres Strait Islander peopleJaimi H Greenslade, Sara Berndt, Laura Stephensen, et al.
Cancer|August 19, 2007
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cellsMichael W N Deininger, Jorge Cortes, Ron Paquette, et al.
Oncotarget|September 9, 2017
Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinaseEllen L Weisberg, Alexandre Puissant, Richard Stone, et al.
Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Heart, Lung & Circulation|March 26, 2022
Emergency Department Assessment of Suspected Acute Coronary Syndrome Using the IMPACT Pathway in Aboriginal and Torres Strait Islander PeopleLouise Cullen, Laura Stephensen, Jaimi Greenslade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemiaEric J Feldman, Joseph Brandwein, Richard Stone, et al.
Emergency Medicine Australasia : EMA|November 21, 2022
Clinical characteristics of Aboriginal and Torres Strait Islander emergency department patients with suspected acute coronary syndromeLaura Stephensen, Jaimi Greenslade, Katrina Starmer, et al.
Molecular Therapy. Oncology|March 24, 2025
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDsWei Ni, Swati Garg, Basudev Chowdhury, et al.
Pageof 55

Showing results (501-510 of 544) with videos related to

Sort By:
Pageof 55
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2010
Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28Jacalyn Rosenblatt, Zekui Wu, Baldev Vasir, et al.
Leukemia|January 25, 2021
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
The Medical Journal of Australia|June 1, 2022
Value of single troponin values in the emergency department for excluding acute myocardial infarction in Aboriginal and Torres Strait Islander peopleJaimi H Greenslade, Sara Berndt, Laura Stephensen, et al.
Cancer|August 19, 2007
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cellsMichael W N Deininger, Jorge Cortes, Ron Paquette, et al.
Oncotarget|September 9, 2017
Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinaseEllen L Weisberg, Alexandre Puissant, Richard Stone, et al.
Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Heart, Lung & Circulation|March 26, 2022
Emergency Department Assessment of Suspected Acute Coronary Syndrome Using the IMPACT Pathway in Aboriginal and Torres Strait Islander PeopleLouise Cullen, Laura Stephensen, Jaimi Greenslade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemiaEric J Feldman, Joseph Brandwein, Richard Stone, et al.
Emergency Medicine Australasia : EMA|November 21, 2022
Clinical characteristics of Aboriginal and Torres Strait Islander emergency department patients with suspected acute coronary syndromeLaura Stephensen, Jaimi Greenslade, Katrina Starmer, et al.
Molecular Therapy. Oncology|March 24, 2025
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDsWei Ni, Swati Garg, Basudev Chowdhury, et al.
Pageof 55